09 - 10 July 2020

MarketsandMarkets Protein and Antibody Engineering Virtual Conference

12+
Speakers
100+
Attendees

Protein-based drugs are a fast-growing class on the pharmaceutical market, with thousands of candidates in development. The most widely applied aspect of the protein engineering is antibody engineering. Bispecific and Monoclonal Abs have revolutionized the field of diagnosis and immunotherapy for the treatment of a variety of diseases.

At our MarketsandMarkets Protein and Antibody Engineering Virtual Conference scheduled on 9th & 10th July 2020 the academic researchers and industry practitioners will share their expertise in the design, discovery and engineering of protein and antibody molecules.

Learn from the key professionals and explore the process while to prove its worth for the research on therapeutics of covid-19.

WHAT TO EXPECT
Key Highlights
  • Covid-19 therapeutics through protein engineering
  • Engineering the scaffolds
  • Design and characterization of antibodies
  • Bispecific & MAbs for immune-oncology and immune based disorders
  • Engineering the HIV antibodies
  • characterization of anti-idiotypic shark antibody domains
Who should attend?

Senior Scientists/ Principal Scientists/ Project Leaders/Heads, Professors/ Assistant Professors/ Researchers/ Scientists/ Principal Scientists working in

  • Molecular Biology
  • Drug discovery
  • Protein biochemistry
  • Protein engineering
  • Immuno-oncology
  • Protein production
  • Antibody discovery
  • Biologics
  • Protein technologies
PAST EVENT GALLERY